• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Cell & Gene Therapy

Charles River Boston Massachusetts
Favicon Fierce Biotech

Charles River to close Maryland CDMO site, lay off 20 staffers

“After a thoughtful review, we determined that our cell therapy facility in Hanover, MD, is not a strategic fit,” a spokesperson told Fierce.
Will Maddox Feb 3, 2026 12:20pm
Vinay Prasad
Favicon Fierce Biotech

FDA to ‘carefully shepherd’ CAR-T for autoimmune disease: Prasad

Feb 3, 2026 11:40am
layoffs employees crossed off

Thermo Fisher winds down Boston area plant

Feb 2, 2026 12:22pm
China Chinese Flag draped over gold bars economy stock market finance
Favicon Fierce Biotech

AstraZeneca vows $15B China investment to boost R&D capabilities

Jan 29, 2026 5:50am
Cellares

Cellares attracts $257M series D to build sites in Japan, Europe

Jan 28, 2026 9:40am
Cellares Corporation

Cellares expands to Europe with new facility in the Netherlands

Jan 12, 2026 2:24pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings